Genetic counseling and predictive testing for colorectal cancer risk

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

In contrast to our rapidly increasing knowledge of the genetic basis of colorectal cancer and new molecular technologies, we are only in the early stages of characterizing the impact that this information will have on patients, their families and society. From our research and clinical experience with hereditary colorectal cancer syndromes, we have developed a framework for risk assessment that includes criteria for identifying those at higher genetic risk and guidelines for genetic counseling, predictive genetic testing and follow-up management. More research is needed to optimally translate this framework into wider clinical practice, including characterizing genetic heterogeneity and phenotype correlations, documenting the efficacy of screening and surgical interventions, and maximizing the awareness of health professionals on genetic counseling and the promise and limitations of gene tests.

Original languageEnglish (US)
Pages (from-to)53-54
Number of pages2
JournalInternational Journal of Cancer
Volume69
Issue number1
DOIs
StatePublished - Feb 20 1996
Externally publishedYes

Fingerprint

Genetic Counseling
Genetic Testing
Colorectal Neoplasms
Hereditary Neoplastic Syndromes
Genetic Heterogeneity
Research
Guidelines
Technology
Phenotype
Health
Genes

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Genetic counseling and predictive testing for colorectal cancer risk. / Petersen, Gloria M.

In: International Journal of Cancer, Vol. 69, No. 1, 20.02.1996, p. 53-54.

Research output: Contribution to journalArticle

@article{5b0b5cfae1d1421ba54a88fcdf710bb4,
title = "Genetic counseling and predictive testing for colorectal cancer risk",
abstract = "In contrast to our rapidly increasing knowledge of the genetic basis of colorectal cancer and new molecular technologies, we are only in the early stages of characterizing the impact that this information will have on patients, their families and society. From our research and clinical experience with hereditary colorectal cancer syndromes, we have developed a framework for risk assessment that includes criteria for identifying those at higher genetic risk and guidelines for genetic counseling, predictive genetic testing and follow-up management. More research is needed to optimally translate this framework into wider clinical practice, including characterizing genetic heterogeneity and phenotype correlations, documenting the efficacy of screening and surgical interventions, and maximizing the awareness of health professionals on genetic counseling and the promise and limitations of gene tests.",
author = "Petersen, {Gloria M}",
year = "1996",
month = "2",
day = "20",
doi = "10.1002/(SICI)1097-0215(19960220)69:1<53::AID-IJC13>3.0.CO;2-L",
language = "English (US)",
volume = "69",
pages = "53--54",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Genetic counseling and predictive testing for colorectal cancer risk

AU - Petersen, Gloria M

PY - 1996/2/20

Y1 - 1996/2/20

N2 - In contrast to our rapidly increasing knowledge of the genetic basis of colorectal cancer and new molecular technologies, we are only in the early stages of characterizing the impact that this information will have on patients, their families and society. From our research and clinical experience with hereditary colorectal cancer syndromes, we have developed a framework for risk assessment that includes criteria for identifying those at higher genetic risk and guidelines for genetic counseling, predictive genetic testing and follow-up management. More research is needed to optimally translate this framework into wider clinical practice, including characterizing genetic heterogeneity and phenotype correlations, documenting the efficacy of screening and surgical interventions, and maximizing the awareness of health professionals on genetic counseling and the promise and limitations of gene tests.

AB - In contrast to our rapidly increasing knowledge of the genetic basis of colorectal cancer and new molecular technologies, we are only in the early stages of characterizing the impact that this information will have on patients, their families and society. From our research and clinical experience with hereditary colorectal cancer syndromes, we have developed a framework for risk assessment that includes criteria for identifying those at higher genetic risk and guidelines for genetic counseling, predictive genetic testing and follow-up management. More research is needed to optimally translate this framework into wider clinical practice, including characterizing genetic heterogeneity and phenotype correlations, documenting the efficacy of screening and surgical interventions, and maximizing the awareness of health professionals on genetic counseling and the promise and limitations of gene tests.

UR - http://www.scopus.com/inward/record.url?scp=0029974661&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029974661&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-0215(19960220)69:1<53::AID-IJC13>3.0.CO;2-L

DO - 10.1002/(SICI)1097-0215(19960220)69:1<53::AID-IJC13>3.0.CO;2-L

M3 - Article

VL - 69

SP - 53

EP - 54

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 1

ER -